Sleep and aging: Prevalence of disturbed sleep and treatment considerations in older adults

Journal of Clinical Psychiatry

Volumn 66, Issue SUPPL. 9, 2005, Pages 24-30

  Ancoli Israel, Sonia ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG;

ANGINA PECTORIS; ASTHMA; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; COMORBIDITY; CONGESTIVE HEART FAILURE; CONSTIPATION; DELIRIUM; DEMENTIA; DEPRESSION; DROWSINESS; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; INSOMNIA; INTRACRANIAL HYPERTENSION; MALAISE; MUSCLE WEAKNESS; PARKINSON DISEASE; PATIENT ASSESSMENT; PHYSICAL DISABILITY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REMISSION; RESTLESS LEGS SYNDROME; REVIEW; RISK FACTOR; SENESCENCE; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PATTERN; URINE INCONTINENCE; URINE RETENTION; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; RECEPTORS, GABA-A; RECEPTORS, MELATONIN; SLEEP; SLEEP DISORDERS;

EID: 29444457363     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Ohayon MM, Carskadon MA, Guilleminault C, et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27:1255-1273
2. National Sleep Foundation. 2002 Sleep in America Poll. April 2, 2002. Available at: http://www.sleepfoundation.org/img/2002SleepInAmericaPoll.pdf. Accessed May 24, 2005
3. National Sleep Foundation. 2003 Sleep in America Poll. March 10, 2003. Available at: http://www.sleepfoundation.org/_content/hottopics/ 2003SleepPollExecSumm.pdf. Accessed May 24, 2005
4. Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425-432
5. Cornoni-Huntley JC, Ostfeld AM, Taylor JO, et al. Established populations of epidemiologic studies of the elderly: study design and methodology. Aging Clin Exp Res 1993;5:27-37
6. Foley DJ, Monjan A, Simonsick EM, et al. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep 1999;22(suppl 2):5366-5372
7. Foley D, Ancoli-Israel S, Britz P, et al. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56:497-502
8. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141
9. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991;14:496-500
10. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-554
11. Hening WA, Allen RP, Barley CJ, et al. An update of the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27:560-583
12. Littner M, Kusida C, Anderson WM, et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27:557-559
13. Shapiro S, Slone D, Lewis GP, et al. Clinical effects of hypnotics, 2: an epidemiologic study. JAMA 1969;209:2016-2020
14. Teutsch G, Mahler DL, Brown CR, et al. Hypnotic efficacy of diphenhydramine, methapyrilene, and pentobarbital. Clin Pharmacol Ther 1975;17:195-201
15. Kudo Y, Kurihara M. Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double-blind study. J Clin Pharmacol 1990;30:1041-1048
16. Meuleman JR, Nelson RC, Clark RLJ. Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population. Drug Intell Clin Pharm 1987;21:716-720
17. Derbez R, Grauer H. A sleep study and investigation of a new hypnotic compound in a geriatric population. Can Med Assoc J 1967;97:1389-1393
18. Russo RM, Gururaj VJ, Allen JE. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. J Clin Pharmacol 1976;16:284-288
19. Richardson GS, Roehrs TA, Rosenthal L, et al. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol 2002;22:511-515
20. Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas: mechanism and management. Drug Saf 2003;26:749-767
21. Ringdahl EN, Pereira SL, Delzell JEJ. Treatment of primary insomnia. J Am Board Fam Pract 2004;17:212-219
22. Schenck CH, Mahowald MW, Sack RL. Assessment and management of insomnia. JAMA 2003;289:2475-2479
23. Agostini JW, Leo-Summers L, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 2001;161:2091-2097
24. Mendelson WB, Caruso C. Pharmacology in sleep medicine. In: Poceta JS, Mitler MM, eds. Sleep Disorders: Diagnosis and Treatment. Totowa, NJ: Humana Press Inc; 1998:137-160
25. Kupfer DJ, Reynolds CF. Management of insomnia. N Engl J Med 1997;336:341-346
26. National Institutes of Health (NIH) Consensus Development Program: NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults [conference statement; June 13-15, 2005]. Available at http://consensus.nih.gov/2005/2005InsomniaSOS026htmlDRAFT.htm. Accessed Aug 12, 2005
27. Scharf MB, Mayleben DW, Kaffeman M, et al. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry 1991;52:77-83
28. Roger M, Attali P, Coquelin J-P. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther 1993;15:127-136
29. Ancoli-Israel S, Walsh JK, Mangano RM, et al. Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Prim Care Companion J Clin Psychiatry 1999;1:114-120
30. Ancoli-Israel S, Richardson GS, Mangano RM, et al. Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med 2005;6:107-113
31. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793-799
32. Roth T, Seiden D, Weigand S, et al. Phase III study to determine the efficacy of ramelteon in elderly patients with chronic insomnia [poster session II-87]. In: Abstracts: Oral and Poster Presentations of the 45th annual meeting of the New Clinical Drug Evaluation Unit; June 6-9, 2005; Boca Raton, Fla. Available at http://www.nimh.nih.gov/ncdeu/2005abstracts.pdf
33. Roth T, Seiden D, van der Zee P, et al. Phase III outpatient trial of ramelteon for the treatment of chronic insomnia in elderly patients [abstract]. J Am Geriatr Soc 2005;53(issue S1):S25
34. Scharf MB, Rosenberg R, Conn M, et al. Safety and efficacy of immediate release indiplon (NBI-34060) in elderly patients with insomnia [abstract 0209.C]. Sleep 2003;26(abstract suppl):A85
35. Walsh JK, Lankford DD, Krystal A, et al. Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia [abstract 0190.C]. Sleep 2003;26 (abstract suppl):A78
36. Morin CM, Stone J, Trinkle D, et al. Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging 1993;8:463-467
37. Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia: an American Academy of Sleep Medicine review. Sleep 1999;22:1134-1156
38. Morin CM, Mimeault V, Gagne A. Nonpharmacological treatment of late-life insomnia. J Psychosom Res 1999;46:103-116
39. Edinger JD, Sampson WS. A primary care "friendly" cognitive behavioral insomnia therapy. Sleep 2003;26:177-182
40. Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized clinical trial. JAMA 1999;281:991-999